Skip to main content

Table 4 Comparison of the in vitro activities of selected antimicrobial agents tested against Acinetobacte spp. a (362 strains)

From: Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005–2010

Antimicrobial agent

MIC50

MIC90

Range

% susceptible / resistantb

 Ceftazidime

>16

>32

≤1 – >16

17.1 / 74.3

 Cefepime

16

>16

≤0.12 – >16

28.7 / 49.4

 Piperacillin / tazobactam

>64

>64

≤0.5 – >64

16.3 / 77.9

 Imipenem

4

>8

≤0.12 – >8

52.3 / 36.4

 Meropenem

4

>8

≤0.12 – >8

52.3 / 37.4

 Ciprofloxacin

>4

>4

≤0.03 – >4

18.2 / 81.2

 Levofloxacin

>4

>4

≤0.5 – >4

18.7 / 78.1

 Gentamicin

>8

>8

≤2 – >8

34.2 / 63.5

 Amikacin

>32

>32

≤4 – >32

22.1 / 64.9

 PolymyxinB

≤0.5

≤0.5

≤0.5 – >4

98.6 / 1.4

 Colistin

≤0.5

1

≤0.5 – >4

98.5 / 1.5

  1. a Includes Acinetobacterbaumannii (295 strains), Acinetobacterhaemolyticus (3 strains), Acinetobacterlwoffii (16 strains), and unspeciated Acinetobacter (48 strains).
  2. b Criteria as published by the CLSI [16].